Gland Pharma Limited
Ravi Mitra has extensive work experience in finance and leadership roles. RAVI most recently served as the Chief Financial Officer at Gland Pharma Limited, where they oversaw finance, investor relations, secretarial, and legal functions. Prior to that, Ravi was the Vice President Finance at Wockhardt Ltd., where they led the global finance team and was responsible for financial reporting, FP&A, investor relations, business finance, and more. RAVI also held the position of General Manager-Corporate Finance at Ranbaxy and Associate General Manager at Vedanta Resources Plc. Ravi started their career at Indian Oil Corporation Limited as a Deputy Manager Finance.
Ravi Mitra has a Chartered Accountant degree from The Institute of Chartered Accountants of India, obtained between 1996 and 1999. Additionally, they have a B.Com in Commerce from St. Xavier's College, earned from 1994 to 1997. Ravi Mitra also pursued a Diploma in Information Systems Audit from The Institute of Chartered Accountants of India, although there is no specific duration provided. Furthermore, Ravi Mitra attended K.V. Ballygunge, Kolkata in 1994, but it is unspecified whether they obtained a degree from this institution.
This person is not in any offices
Gland Pharma Limited
1 followers
Established in Hyderabad, India in 1978, Gland Pharma is one of the fastest-growing small-molecule generic injectables-focused company, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets in the rest of the world. Gland Pharma has seven manufacturing facilities in India, comprising four facilities for finished formulations and three API facilities. We are focused on meeting diverse injectables needs with a stable supply of affordable and high-quality products. We have established a portfolio of injectables products across various therapeutic segments and delivery systems and are present in sterile injectables, oncology and ophthalmics with a focus on complex injectables.